文献速递神经CT

临床光子计数CT在神经放射学的真实世界配对比较

Clinical Photon-Counting CT in Neuroradiology: A Real-World Paired Comparison with Conventional Energy-Integrating CT.
PubMed 文献 · AJNR Am J Neuroradiol · 2026-08-13

本研究回顾性纳入194例接受常规临床光子计数CT且3个月内有同部位传统能量积分CT的成人患者,共270对检查。由4名设盲读片者评估图像质量与病变显著性,比较CNR、剂量归一化CNR及辐射剂量。主要结论为平扫脑CT中PCCT图像质量、病变显著性、灰白质CNR及剂量效率更高。

要点

  • 平扫脑CT中PCCT总体图像质量及病变显著性评分均高于EID-CT。
  • PCCT灰白质CNR提高102%-152%,剂量归一化CNR提高128%-180%。
  • PCCT中位剂量较EID-CT降低22%,但伪影评分无显著差异。

核心结论

  • 常规平扫脑CT中,PCCT与更高的图像质量、病变显著性、灰白质CNR及剂量归一化CNR和更低的辐射剂量相关。
  • 因扫描仪代际、厂商、扫描方案及重建方式均未匹配,组间差异不能仅归因于探测器技术。
  • 增强脑CT与动脉/静脉CTA亚组为探索性分析,结果不强化主要结论。

研究设计与样本

  • 回顾性配对研究,纳入2023年12月至2024年2月连续接受临床PCCT且3个月内有同部位EID-CT的成人患者。
  • 共194例患者,平均年龄65±15岁,男性100例,贡献270对检查。
  • 按扫描方案分组:平扫脑CT225对为主队列,增强脑CT14对、动脉CTA26对、静脉CTA5对为探索性队列。
  • 4名设盲读片者评估图像质量与病变显著性,配对图像间隔至少4周分次评阅。
  • 采用Wilcoxon符号秩检验比较CNR、剂量归一化CNR(CNRD)与辐射剂量。

关键影像表现/征象

  • 平扫脑CT中PCCT总图像质量评分中位数为4分,高于EID-CT的3分。
  • 224/225对平扫脑CT中PCCT时间无关病变显著性评分更高,中位数为4分对3分。
  • 探索性CTA分析中PCCT穿支血管显示评分更高,中位数为3分对2分。
  • 平扫脑CT中PCCT与EID-CT伪影评分差异无统计学意义。

诊断标准与关键数值

  • 平扫脑CT总体图像质量评分:PCCT中位数4分对EID-CT 3分(p<.001)。
  • 时间无关病变显著性:PCCT在224/225对中优于EID-CT,中位数4分对3分(p<.001)。
  • 平扫脑CT灰白质CNR:PCCT较EID-CT提高102%-152%(p<.001)。
  • 剂量归一化CNR(CNRD):PCCT较EID-CT提高128%-180%(p<.001)。
  • 中位辐射剂量:PCCT为38.4 mGy,EID-CT为49.2 mGy,PCCT降低22%(p<.001)。

临床应用与阅片要点

  • 临床平扫脑CT选用PCCT有望在常规工作中兼顾更高灰白质对比和更低辐射剂量。
  • PCCT对细小血管如穿支动脉显示更优,在CTA评价中可能具备潜在优势。
  • 解读PCCT与EID-CT图像对比时需注意扫描仪代际、厂商及重建算法差异可能混淆结果。

局限性

  • 扫描仪代际、厂商、扫描方案及重建方式存在差异,无法将观察到的优势单独归因于光子计数探测器本身。
  • 增强脑CT、动脉CTA及静脉CTA亚组样本量小,仅为探索性分析。
  • 回顾性单中心设计,存在选择偏倚可能。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: Photon-counting CT offers higher spatial resolution, improved contrast-to-noise efficiency, and spectral imaging, but its performance against heterogeneous EID-CT systems in routine use remains incompletely characterized. We compared image quality, pathology conspicuity, and radiation dose between clinical PCCT and EID-CT in paired routine neuroradiological examinations, accounting for differences in scanner generation, protocol, and reconstruction. We hypothesized higher image-quality and pathology-conspicuity scores and dose efficiency, while treating the comparison as pragmatic rather than detector-isolating.

MATERIALS AND METHODS: This retrospective study included consecutive adults undergoing routine clinical PCCT from December 2023 through February 2024 who had a corresponding same-region EID-CT within three months; when several EID-CT scans were eligible, the closest in time was selected. Examinations were grouped by protocol: non-contrast brain CT was the primary cohort; contrast-enhanced brain CT and arterial and venous CTA were exploratory. Four blinded readers assessed image quality and pathology conspicuity, with paired scans assigned to separate sessions at least four weeks apart. CNR, dose-normalized CNR (CNRD), and radiation dose were compared within subjects using the Wilcoxon signed-rank test.

RESULTS: The 194 patients (mean age, 65±15 years; 100 males) contributed to 270 pairs: 225 non-contrast brain CTs, 14 contrast-enhanced brain CTs, 26 arterial CTAs, and 5 venous CTAs. In the primary cohort, PCCT was associated with higher overall image-quality scores (median 4 versus 3; p<.001), higher time-independent pathology conspicuity in 224/225 pairs (median 4 versus 3; p<.001), 102%-152% higher GM/WM CNR, 128%-180% higher CNRD, and 22% lower median dose (38.4 versus 49.2 mGy; all p<.001). All three primary endpoints remained significant in the ≤1-day subset (n=60). Artifact scores did not differ significantly. Exploratory contrast-enhanced and angiographic analyses favored PCCT for selected parenchymal and small-vessel metrics, including perforator visualization (median 3 versus 2; p<.001), but these small subgroups were preliminary and did not strengthen the primary conclusions.

CONCLUSIONS: PCCT was associated with higher image quality, pathology conspicuity, GM/WM CNR and CNRD, and lower dose in routine non-contrast brain CT. Smaller protocol groups were exploratory. Because scanner generations, vendors, protocols, and reconstructions were unmatched, the differences cannot be attributed solely to detector technology.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Szum, Moberg, Kalarakis, et al. Clinical Photon-Counting CT in Neuroradiology: A Real-World Paired Comparison with Conventional Energy-Integrating CT. AJNR Am J Neuroradiol. 2026. PMID: 42595467. doi:10.3174/ajnr.A9588

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。